Parkinson’s disease

On the right path in Feinstein Parkinson’s pursuit

By GREGORY ZELLER // A new gene therapy can literally rewire the brains of Parkinson’s disease patients – and may rewrite the book on treatment of the nation’s second most-common neurodegenerative disease. A team of scientists from the Manhasset-based Feinstein Institute for Medical Research has published findings indicating that AAV2-GAD, an emerging Parkinson’s gene therapy, creates new circuits in the brain promoting improved motor skills – setting up AAV2-GAD for a critical final found of…


Hey, Biff … that’s DOCTOR McFly to you

At long last, teen hero Marty McFly will go degree-for-degree with his partner in time, Dr. Emmett Brown: Stony Brook University will confer an honorary Doctor of Fine Arts degree upon Canadian-American actor Michael J. Fox during its 2017 commencement ceremony. Fox – whose award-winning, three-decade entertainment career also includes stints as a producer, author and voice performer – is a respected advocate for several important causes, and one in particular: With the exception, perhaps,…


Novel Parkinson’s Procedure Pumps Up NSUH

By GREGORY ZELLER // They’re dancing in the aisles, literally, at North Shore University Hospital, thanks to a revolutionary treatment for Parkinson’s disease. Surgeons at the Manhasset hospital, part of the Northwell Health system, recently completed their first endoscopic procedure involving Duopa, an effective drug combo administered via a cutting-edge cassette-pump system marketed by Chicago-based pharma AbbVie Inc. Approved by the FDA in January, Duopa marks the first Parkinson’s disease treatment to administer medicine –…